Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate

Overview of attention for article published in Journal of Translational Medicine, June 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 78 followers.

Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and… https://t.co/AjBRl80WzC #JTransMed

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.